Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 11535502)

Published in Blood on September 15, 2001

Authors

D K Webb1, G Harrison, R F Stevens, B G Gibson, I M Hann, K Wheatley, MRC Childhood Leukemia Working Party

Author Affiliations

1: Great Ormond Street Hospital for Children, London, United Kingdom. david.webb@gosh-tr.nthames.nhs.uk

Associated clinical trials:

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia | NCT00002658

Articles citing this

Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group. Blood (2007) 3.11

Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia. Leuk Lymphoma (2014) 1.59

The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study. Pediatr Blood Cancer (2010) 1.59

Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group. Cancer (2013) 1.14

Characterization of pediatric acute lymphoblastic leukemia survival patterns by age at diagnosis. J Cancer Epidemiol (2014) 0.94

Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia. Bone Marrow Transplant (2004) 0.91

Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults. BMC Cancer (2015) 0.84

Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma. Cancer (2016) 0.83

Development of five dual-color, double-fusion fluorescence in situ hybridization assays for the detection of common MLL translocation partners. J Mol Diagn (2010) 0.78

Infants with acute myeloid leukemia treated according to the Associazione Italiana di Ematologia e Oncologia Pediatrica 2002/01 protocol have an outcome comparable to that of older children. Haematologica (2014) 0.77

Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: Evidence from US population data. Cancer Epidemiol (2015) 0.77

Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial. J Clin Oncol (2016) 0.76

Impact of age on the survival of pediatric leukemia: an analysis of 15083 children in the SEER database. Oncotarget (2016) 0.75

Acute myeloid leukemia in infants: biology and treatment. Front Pediatr (2015) 0.75

Articles by these authors

Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ (1994) 23.80

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood (1998) 11.58

CONSTANS mediates between the circadian clock and the control of flowering in Arabidopsis. Nature (2001) 6.94

Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) (1988) 6.76

Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ (1994) 6.74

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood (2001) 5.34

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood (2001) 5.20

Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. Br J Psychiatry (2000) 4.44

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet (2001) 4.14

Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ (2001) 3.81

Amelogenin-deficient mice display an amelogenesis imperfecta phenotype. J Biol Chem (2001) 3.50

Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma. J Clin Oncol (2003) 3.13

14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet (1987) 2.68

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial. Blood (2001) 2.61

The prevalence and trends of overweight, obesity and nutrition-related non-communicable diseases in the Arabian Gulf States. Obes Rev (2011) 2.37

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia (2005) 2.35

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties. Br J Haematol (1999) 2.24

Supervision registers for mentally ill people. BMJ (1994) 2.14

Guidelines for the diagnosis and management of hereditary spherocytosis. Br J Haematol (2004) 2.12

Prevalence of substance misuse in first-episode psychosis. Br J Psychiatry (1999) 2.09

Care-seeking for fatal illnesses in young children in Indramayu, west Java, Indonesia. Lancet (1993) 2.02

Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet (1982) 2.01

Serum IgG subclass concentrations in healthy adults: a study using monoclonal antisera. Clin Exp Immunol (1984) 1.99

Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther (1992) 1.99

Nutrition, infection, and morbidity in leukemia. Pediatr Hematol Oncol (1988) 1.94

Patterns and predictors of hospitalisation in first-episode psychosis. Prospective cohort study. Br J Psychiatry (2001) 1.87

The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand (2006) 1.76

Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med (1993) 1.74

Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council. Blood (1997) 1.73

Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. Br J Haematol (1997) 1.72

Pathways to care and ethnicity. 1: Sample characteristics and compulsory admission. Report from the AESOP study. Br J Psychiatry (2005) 1.70

Matrix metalloproteinase-1 and skin ageing in smokers. Lancet (2001) 1.69

Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications. Q J Med (1994) 1.67

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party. Br J Haematol (1998) 1.67

Is food insufficiency associated with health status and health care utilization among adults with diabetes? J Gen Intern Med (2001) 1.61

Characteristics of outcome in schizophrenia at 13 years. Br J Psychiatry (1995) 1.60

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol (1997) 1.59

The Ty1-copia group retrotransposons in Vicia species: copy number, sequence heterogeneity and chromosomal localisation. Mol Gen Genet (1996) 1.59

A modified fascia iliaca compartment block has significant morphine-sparing effect after total hip arthroplasty. Anaesth Intensive Care (2007) 1.58

Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial. Br J Haematol (2001) 1.58

Testicular histology after combination chemotherapy in childhood for acute lymphoblastic leukaemia. Lancet (1978) 1.57

FLAG (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children. Med Pediatr Oncol (1999) 1.57

Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication. Aliment Pharmacol Ther (1991) 1.56

Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. J Hum Hypertens (2007) 1.54

How to avoid bias when comparing bone marrow transplantation with chemotherapy. Bone Marrow Transplant (1991) 1.52

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties. Lancet (1998) 1.52

Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol Med (2000) 1.48

Systemic antibody deficiency in patients without serum immunoglobulin deficiency or with selective IgA deficiency. Clin Exp Immunol (1984) 1.48

Systematic assessments of need and care planning in severe mental illness: cluster randomised controlled trial. Br J Psychiatry (2004) 1.47

A score at diagnosis for predicting length of remission in childhood acute lymphoblastic leukaemia. Br J Cancer (1980) 1.47

Long-term follow-up of schizophrenia in 16 countries. A description of the International Study of Schizophrenia conducted by the World Health Organization. Soc Psychiatry Psychiatr Epidemiol (1996) 1.44

Premorbid personality in first-onset psychosis. Br J Psychiatry (1994) 1.42

Pseudo-Gaucher cells. J Clin Pathol (1992) 1.41

Prognostic importance of Sudan Black positivity: a study of bone marrow slides from 1,386 patients with de novo acute myeloid leukaemia. Br J Haematol (1991) 1.41

Post-traumatic stress disorder. Br J Psychiatry (1990) 1.40

The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison. Leukemia (2012) 1.39

Minimal residual disease in childhood acute lymphoblastic leukaemia. Lancet (1994) 1.39

Are glomerular filtration rate estimations necessary before high dose methotrexate? Arch Dis Child (1999) 1.38

Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin Exp Immunol (1984) 1.37

Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J (Clin Res Ed) (1983) 1.37

Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial. Blood (1999) 1.33

Long-term retrograde amnesia...the crucial role of the hippocampus. Neuropsychologia (2001) 1.31

Nutrition transition in the United Arab Emirates. Eur J Clin Nutr (2011) 1.29

The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study. Br J Haematol (2000) 1.28

Dopamine agonist therapy in early Parkinson's disease. Cochrane Database Syst Rev (2008) 1.28

"Eradication" of Campylobacter pylori: are we being misled? Lancet (1988) 1.26

Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood (2001) 1.24

High altitude pulmonary edema and exercise at 4,400 meters on Mount McKinley. Effect of expiratory positive airway pressure. Chest (1985) 1.23

Testicular function after combination chemotherapy in childhood for acute lymphoblastic leukaemia. Arch Dis Child (1981) 1.22

Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party. Br J Haematol (1996) 1.21

Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MCR Childhood Leukaemia Working Party. Br J Haematol (1999) 1.19

Psychiatric hospital admissions in Bristol. I. Geographical and ethnic factors. Br J Psychiatry (1984) 1.19

The prognostic significance of morphological features in childhood acute lymphoblastic leukaemia. Clin Lab Haematol (1979) 1.19

The pharmacokinetics of ketoconazole in severely immunocompromised patients. J Antimicrob Chemother (1982) 1.17

The roles of annexins and types II and X collagen in matrix vesicle-mediated mineralization of growth plate cartilage. J Biol Chem (2000) 1.17

Pathways to care and ethnicity. 2: Source of referral and help-seeking. Report from the AESOP study. Br J Psychiatry (2005) 1.17

Investigating whether adverse prenatal and perinatal events are associated with non-clinical psychotic symptoms at age 12 years in the ALSPAC birth cohort. Psychol Med (2009) 1.16

Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol. Leukemia (2010) 1.16

The impact of prophyactic treatment on children with severe haemophilia. Br J Haematol (1996) 1.15

Guidelines on the management of acute myeloid leukaemia in adults. Br J Haematol (2006) 1.15

Reinfection or recrudescence after apparently successful eradication of Helicobacter pylori infection: implications for treatment of patients with duodenal ulcer disease. Q J Med (1993) 1.15

Development of pluripotent hematopoietic progenitor cells in the human fetus. Blood (1983) 1.15

Diagnostic stability of first-episode psychosis. Comparison of ICD-10 and DSM-III-R systems. Br J Psychiatry (1999) 1.15

Evidence that an HLA-DQA1-DQB1 haplotype influences susceptibility to childhood common acute lymphoblastic leukaemia in boys provides further support for an infection-related aetiology. Br J Cancer (1998) 1.14

The prognostic significance of radiological and symptomatic bone involvement in childhood acute lymphoblastic leukaemia. Med Pediatr Oncol (1979) 1.14

Prognostic significance of cell surface markers in childhood acute lymphoblastic leukaemia. Clin Lab Haematol (1979) 1.14

Haematological abnormalities in Shwachman-Diamond syndrome. Br J Haematol (1996) 1.12